For over 35 years, ePTFE has been a mainstay of the cardiovascular device … [Read More...]
White Papers
Insights Into Drug Delivery Device Manufacturing From Development Through Commercialization
Biologics and other targeted therapies are creating opportunities for … [Read More...]
Sponsored Content
Life in the Fast Lane: 3 Lean Tools to Speed Products to Market
By Don Welling, Sr. Director of Technical Solutions, Viant The average driver can change a tire in about 20 minutes. A NASCAR pit crew can change all four tires in less than 20 seconds, thanks to … [Read More...]
The need for new business models under MDR/IVDR
In less than 12 months, the world’s second largest market for medical technologies is going to be turned upside down. The new medical devices regulation (MDR) and in vitro diagnostic device regulation … [Read More...]
5 Guidelines for Writing a Useful Clinical Monitoring Report
Taking Your Report from Good to Great By Brandy Chittester, Chief of Clinical Operations A well-written monitoring report is an essential part of documenting clinical trial oversight. In addition … [Read More...]
Mergers & Acquisitions.
Merged Smithwise and Catapult rebrand as Archimedic
After announcing their merger last month, medical product development firms Smithwise and Catapult Product Development have rolled out their new brand, Archimedic. “As we brainstormed a new name, we knew we wanted it to reflect the medical device industry we serve,” said Eric Sugalski, CEO of the joint entity, in explaining in a news release how they settled […]
Varian Medical to pick up Cancer Treatment Services Int’l for $283m
Varian Medical (NYSE:VAR) said today that it inked a deal to acquire Cancer Treatment Services International for $283 million. Privately held CTSI operates the Hyderabad-based American Oncology Institute and 10 multidisciplinary radiation, medical and surgical oncology cancer centers across the Indian subcontinent and a U.S.-based oncology solutions division, Palo Alto, Calif.-based Varian said. Varian said that […]
DeviceTalks partners with New England Healthcare Executive Network to host mergers & acquisition panel at DeviceTalks Boston
The New England Healthcare Executive Network will host a panel of leaders to discuss the topic of mergers and acquisitions in the medical device industry. For the third consecutive year, DeviceTalks has partnered with the New England Healthcare Executive Network at DeviceTalks Boston. At DeviceTalks Boston 2019, NE Healthcare Executive Network’s member meeting will offer […]
Haemonetics deals S.C. plant to CSL Plasma for $10m
Haemonetics (NYSE:HAE) said today that it agreed to sell a plant in South Carolina to CSL Plasma for $10 million. The Union, S.C., facility makes the liquid saline and sodium citrate solutions used in plasma collection. CSL Plasma, the supplier for CSL Behring, will own and operate the plant, taking on “substantially all” of the roughly […]
WishBone Medical acquires CSpine
WishBone Medical said late last week that it acquired Indiana-based spine and orthopedic implant and instrument maker CSpine in an undisclosed deal. Warsaw, Ind.-based WishBone Medical said that its acquisition of CSpine will help the company enter a key segment in pediatric orthopedics and address the needs of children with spinal deformities. “Our foundation supporting […]
Histogenics completes transformation into Ocugen with $7m deal for NeoCart
UPDATED May 14, 2019, with comment from Medavate. Histogenics (NSDQ:HSGX) said today that it completed another step on its transformation into clinical-stage biopharmaceutical company Ocugen, with a nearly $7 million deal to sell its NeoCart regenerative knee treatment to Medavate. The $6.5 million all-cash deal, signed May 8, will see all of the NeoCart assets pass […]
Neovasc plunges on Q1 misses
Neovasc (NSDQ:NVCN) shares are taking a beating this morning after the company released first-quarter results yesterday that badly missed the consensus forecast. Vancouver-based Neovasc pared its losses by -85.7% to -$7.9 million, or -21¢ per share, on sales growth of 72.3% to $585,800 compared with Q1 2018. Analysts on Wall Street were looking for losses […]
MassDevice Network
@MassDevice
LinkedIn
YouTube